drugset / Trial / NCT01456546
Impact of CYP2C19*17 on the Pharmacokinetics of Proguanil and Clopidogrel
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The aim of this study is to investigate if the genetic variant CYP2C19\*17 affects the pharmacokinetics of proguanil and clopidogrel.
Timeline
- Start
- 2011-10
- Primary completion
- 2013-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clopidogrel | Small molecule | 300 mg | — |
| Comparator | Proguanil | Small molecule | 350 mg | — |
Indications
No indication recorded.